Competitive Generic Therapies: Off-Patent Drugs With 1 Source
✉ Email this page to a colleague
This table lists drugs which, despite having no patents or regulatory protections, have a limited number of active sources.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Strength |
---|---|---|---|---|---|---|---|---|---|---|
Mission Pharma | LITHOSTAT | acetohydroxamic acid | TABLET;ORAL | 018749-001 | May 31, 1983 | RX | Yes | Yes | 250MG | |
Bausch And Lomb | MIOCHOL-E | acetylcholine chloride | FOR SOLUTION;OPHTHALMIC | 020213-001 | Sep 22, 1993 | RX | Yes | Yes | 20MG/VIAL | |
Ge Healthcare | OPTISON | albumin human | INJECTABLE;INJECTION | 020899-001 | Dec 31, 1997 | RX | Yes | Yes | 10MG/ML | |
3m | AVAGARD | alcohol; chlorhexidine gluconate | SOLUTION;TOPICAL | 021074-001 | Jun 7, 2001 | OTC | Yes | Yes | 61%;1% | |
Concordia | PANRETIN | alitretinoin | GEL;TOPICAL | 020886-001 | Feb 2, 1999 | RX | Yes | Yes | EQ 0.1% BASE | |
Chattem Sanofi | GAVISCON | aluminum hydroxide; magnesium trisilicate | TABLET, CHEWABLE;ORAL | 018685-001 | Dec 9, 1983 | OTC | Yes | No | 80MG;20MG | |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Strength |